Photo credit: DiasporaEngager (www.DiasporaEngager.com).
Kathryn Lee, MPH1; Lindsay Trujillo, MPH2; Evelyn Olansky, MPH2; Taylor Robbins, MPH1; Christine Agnew Brune, PhD1; Elana Morris, MPH1; Teresa Finlayson, PhD1; Dafna Kanny, PhD1; Cyprian Wejnert, PhD1; National HIV Behavioral Surveillance among Transgender Women Study Group (View author affiliations)
What is already known about this topic?
Transgender women are disproportionately affected by HIV.
What is added by this report?
During 2019–2020, 38% of transgender women surveyed in seven major U.S. cities reported receiving a previous positive HIV test result. Low income (44%), experiencing homelessness (39%), and severe food insecurity (40%) were common and associated with lower likelihood of receipt of HIV prevention and health care; having a health care provider with whom the participant is comfortable was positively associated with receiving those services.
What are the implications for public health practice?
Ensuring access to basic needs, such as housing, food, and income, and providing gender-affirming health care could improve access to and use of HIV prevention and treatment services by transgender women.
Views equals page views plus PDF downloads
Transgender women* are disproportionately affected by HIV. Among 1,608 transgender women who participated in CDC’s National HIV Behavioral Surveillance (NHBS) during 2019–2020, 42% received a positive HIV test result (1). This report provides results from seven U.S. urban areas where the 2019–2020 NHBS questionnaire was administered. Thirty-eight percent of participants reported having previously received a positive test result for HIV. Detrimental socioeconomic factors, including low income (44%), homelessness (39%), and severe food insecurity in the past 12 months (40%), were common and associated with lower receipt of HIV prevention and treatment services. Having a usual health care source or a provider with whom the participant was comfortable discussing gender-related health issues was associated with improved HIV prevention and treatment outcomes, including HIV testing, preexposure prophylaxis (PrEP) use, and viral suppression. These findings illustrate the benefit of gender-affirming approaches used by health care providers (2), and highlight the challenging socioeconomic conditions faced by many transgender women. Ensuring access to gender-affirming health care approaches and addressing the socioeconomic challenges of many transgender women could improve access to and use of HIV prevention and care in this population and will help achieve the goals of the Ending the HIV Epidemic in the United States initiative (3).
Initiated in 2003, NHBS conducts biobehavioral surveillance among persons at high risk for HIV infection. During June 2019–February 2020, NHBS surveyed 1,608 transgender women in seven U.S. urban areas using respondent-driven sampling.† Eligible participants§ completed an interviewer-administered questionnaire and were offered an HIV test. The questionnaire included measures of gender identity,¶ income, health insurance, housing,** food insecurity,†† HIV status, viral suppression (if HIV-positive), comfort with their health care provider in discussing gender-related health issues (hereafter referred to as comfort with a provider), unmet need for health care,§§ and usual source of health care. Because of racial and ethnic disparities in HIV prevalence, recruitment was focused on Black or African American and Hispanic or Latina transgender women as initial sampling recruits. Incentives were provided for completion of the interview and HIV test. Adjusted prevalence ratios (aPRs) and 95% CIs for prevention and treatment outcomes, by self-reported HIV status, were estimated using log-linked Poisson regression models with generalized estimating equations clustered on recruitment chain and urban area; models were adjusted for age, race and ethnicity, and urban area. Analyses were conducted using SAS software (version 9.4; SAS Institute). This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.¶¶
Data from 1,608 transgender women were included in this analysis (Table 1). Thirty-eight percent reported having previously received a positive HIV test result.*** Forty-four percent earned <$10,000 annually. During the past 12 months 39% experienced homelessness, and 40% experienced severe food insecurity. Nearly one third (31%) of participants were interviewed in Los Angeles. By urban area, reports of homelessness ranged from 22% to 59%, and reports of recent severe food insecurity ranged from 28% to 47%. Comfort with a provider varied by urban area from 66% to 91%.
Socioeconomic status and health care accessibility were associated with health outcomes (Table 2). Among participants who reported a previous positive test result for HIV, self-reported viral suppression was less common among participants who reported experiencing homelessness during the past 12 months (aPR = 0.88; p = 0.003), and the likelihood of viral suppression decreased as the number of nights of homelessness increased. Severe food insecurity (aPR = 0.84; p<0.001) and unmet need for health care (aPR = 0.89; p = 0.027) were also less common among participants who reported viral suppression. Comfort with a provider (aPR = 1.17; p = 0.007) was more common among participants who reported viral suppression. Similar associations were found for current use of antiretroviral medication. Having a usual source of health care was also associated with current use of antiretroviral medication (aPR = 1.16; p = 0.015).
Among participants who did not report a previous positive test result for HIV, testing for HIV during the past 12 months was more likely among those who reported having a usual source of health care (aPR = 1.16; p<0.001) and comfort with a provider (aPR = 1.12; p = 0.004) (Table 3). PrEP use was more common among participants who reported having health insurance (aPR = 1.54; p<0.001), a usual source of health care (aPR = 2.54; p<0.001), and comfort with a provider (aPR = 1.79; p<0.001), and less likely among participants who reported an unmet need for health care (aPR = 0.82; p = 0.050). PrEP use was also more common among participants who had experienced severe food insecurity than those who had not (aPR = 1.23; p = 0.024).
Experiencing homelessness, poverty, and food insecurity was common among transgender women and might result from the pervasive experience of stigma and discrimination, which reduce access to education, employment, and health care (4). These structural factors are associated with lower likelihood of viral suppression among transgender women with HIV infection. When a person experiences challenges securing food or housing, prioritization of HIV treatment might be interrupted (5). Facilitating transgender women’s access to interventions that address socioeconomic conditions, such as the U.S. Department of Housing and Urban Development’s Housing Opportunities for Persons with AIDS (HOPWA) program,††† could help ensure that basic needs are met and improve the health of persons with HIV in this population.
Despite existence of need-based programs like the Ryan White HIV/AIDS Program§§§ and Ready, Set, PrEP,¶¶¶ results indicate that participants without health insurance or with an unmet need for health care were less likely to achieve viral suppression or report PrEP use. Evaluation of these and similar programs might help identify barriers to participation that need to be addressed to ensure that persons in need are aware of and accessing these programs.
Having a usual source of health care and comfort with a provider were associated with a higher likelihood of viral suppression, HIV testing, and PrEP use, all of which play key roles in HIV prevention. Comfort with a provider can help alleviate the stigma and discrimination that often deter transgender persons from seeking care (6). Perceived interactions with hormones, concerns about side effects, medical mistrust, competing priorities, and the belief that PrEP is specifically for gay men are all documented barriers to PrEP use among transgender persons (7). A gender-affirming provider can help transgender women overcome barriers to PrEP use.
The findings in this report are subject to at least four limitations. First, the results are not representative of all transgender women residing outside the seven urban areas. Second, the data are self-reported and are subject to recall and social desirability biases. Third, the findings reported here are associations, and causality cannot be inferred. Finally, gender-affirming health care is a complex, multifaceted construct (8), and is not fully described by the measure of comfort with a provider when discussing gender-related health issues that was used in this analysis.
Early detection of HIV, appropriate treatment, and proven prevention interventions are effective tools in the fight against HIV and are key strategies for ending the HIV epidemic (3). The findings in this report highlight an additional need for health care providers and other public health officials to ensure appropriate levels of cultural competency when providing services for transgender persons. Providers can use CDC’s Patient-Centered Care for Transgender People: Recommended Practices for Health Care Settings**** as a starting point for understanding how to provide affirming services. Although access to health insurance and gender-affirming health care is critical to connecting transgender women to HIV prevention and care services; access to food, housing, and income are also essential.
National HIV Behavioral Surveillance among Transgender Women Study Group
Narquis Barak, CrescentCare; Kathleen A. Brady, Philadelphia Department of Public Health; Sarah Braunstein, New York City Department of Health and Mental Hygiene; Jasmine Davis, CrescentCare; Sara Glick, University of Washington, School of Medicine, Division of Allergy and Infectious Diseases, Public Health – Seattle & King County, HIV/STD Program; Andrea Harrington, Philadelphia Department of Public Health; Jasmine Lopez, New York City Department of Health and Mental Hygiene; Yingbo Ma, Los Angeles County Department of Public Health; Aleks Martin, Public Health – Seattle & King County, HIV/STD Program; Genetha Mustaafaa, Georgia Department of Public Health; Tanner Nassau, Philadelphia Department of Public Health; Gia Olaes, Los Angeles County Department of Public Health; Jennifer Reuer, Washington State Department of Health; Alexis Rivera, New York City Department of Health and Mental Hygiene; William T. Robinson, Louisiana State University Health Science Center in New Orleans – School of Public Health, Louisiana Office of Public Health STD/HIV/Hepatitis Program; Ekow Kwa Sey, Los Angeles County Department of Public Health; Sofia Sicro, San Francisco Department of Public Health; Brittany Taylor, Georgia Department of Public Health; Dillon Trujillo, San Francisco Department of Public Health; Erin Wilson, San Francisco Department of Public Health; Pascale Wortley, Georgia Department of Public Health.
- CDC. HIV infection, risk, prevention, and testing behaviors among transgender women—National HIV Behavioral Surveillance, 7 U.S. cities, 2019–2020. HIV surveillance special report no. 27. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html
- Carter JW Jr, Salabarría-Peña Y, Fields EL, Robinson WT. Evaluating for health equity among a cluster of health departments implementing PrEP services. Eval Program Plann 2021;101981. https://doi.org/10.1016/j.evalprogplan.2021.101981external icon PMID:34392968external icon
- Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. End the HIV epidemic: a plan for the United States. JAMA 2019;321:844–5. https://doi.org/10.1001/jama.2019.1343external icon PMID:30730529external icon
- Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M. Injustice at every turn: a report of the National Transgender Discrimination Survey. Washington, DC: National Center for Transgender Equality and National Gay and Lesbian Task Force; 2011. https://transequality.org/sites/default/files/docs/resources/NTDS_Report.pdfpdf iconexternal icon
- Hotton AL, Perloff J, Paul J, et al. Patterns of exposure to socio-structural stressors and HIV care engagement among transgender women of color. AIDS Behav 2020;24:3155–63. https://doi.org/10.1007/s10461-020-02874-6external icon PMID:32335760external icon
- Lacombe-Duncan A, Kia H, Logie CH, et al. A qualitative exploration of barriers to HIV prevention, treatment and support: perspectives of transgender women and service providers. Health Soc Care Community 2021;29:e33–46. https://doi.org/10.1111/hsc.13234external icon PMID:33237600external icon
- Cahill SR, Keatley J, Wade Taylor S, et al. “Some of us, we don’t know where we’re going to be tomorrow.” Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco. AIDS Care 2020;32:585–93. https://doi.org/10.1080/09540121.2019.1659912external icon PMID:31482726external icon
- CDC. Patient-centered care for transgender people: recommended practices for health care settings. Atlanta, GA: US Department of Health and Human Services, CDC; 2022. Accessed January 21, 2022. https://www.cdc.gov/hiv/clinicians/transforming-health/health-care-providers/affirmative-care.html
Suggested citation for this article: Lee K, Trujillo L, Olansky E, et al. Factors Associated with Use of HIV Prevention and Health Care Among Transgender Women — Seven Urban Areas, 2019–2020. MMWR Morb Mortal Wkly Rep 2022;71:673–679. DOI: http://dx.doi.org/10.15585/mmwr.mm7120a1external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to
Source of original article: Centers for Disease Control and Prevention (CDC) / HIV (tools.cdc.gov).
The content of this article does not necessarily reflect the views or opinion of Global Diaspora News (www.GlobalDiasporaNews.com).
Sign up to Global Diaspora News newsletter (https://www.GlobalDiasporaNews.com/newsletter/) to start receiving updates and opportunities directly in your email inbox for free.